Nuwellis Shareholders Approve Key Resolutions to Support Growth and Financial Flexibility

Nuwellis Shareholders Give Thumbs Up to All Resolutions in Virtual Special Meeting MINNEAPOLIS, August 4, 2025—Nuwellis, Inc. (NASDAQ: NUWE), a medical technology firm specializing in fluid management solutions, announced that its shareholders have approved all resolutions proposed at the company's recent virtual special meeting. The approved resolutions are aimed at bolstering the company's financial agility and supporting its strategic expansion initiatives. Key decisions include: - Approving the issuance of common shares upon exercise of warrants from the June 10, 2025 financing round, enabling full utilization of committed capital. - Amending the company's Certificate of Incorporation to double the authorized shares from 100 million to 200 million. - Approving a reverse stock split ranging from 1-for-5 to 1-for-70, at the discretion of the board, to maintain compliance with NASDAQ listing requirements. "We are grateful for the strong backing from our shareholders," stated CEO John Erb. "These approvals are vital steps toward strengthening our financial position and enabling us to pursue our long-term growth strategy." Final voting results will be disclosed in a Form 8-K filing ...